Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 33342-138

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 33342-138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30s-daman (30 Daman)

30s-daman (30 Daman)
This is a description of a medication product named Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Tablets containing 600 mg Efaverinz, 200 mg Emtricitabine, and 300 mg Tenofovir Disoproxil Fumarate. It was produced by Macloods Pharma USA Inc. in Princeton, NJ. The medication should be dispensed only in its original container and stored at 68°-77°F. It is advised to avoid medications that should not be taken with this product, and the patient information leaflet should be provided with the medication.*
FDA Label Image

Str1 (Str 1)

FDA Label Image

Str2 (Str 2)

FDA Label Image

Str3 (Str 3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.